Sinovac Biotech Ltd. is biopharmaceutical company that focuses on research, development,
manufacturing and commercialization of
vaccines that protect against human infectious diseases including hepatitis A and
B, seasonal influenza, H5N1 pandemic influenza and mumps, as well as animal rabies
vaccine.
In January 2006, VaxGen granted to GSID a worldwide license to research, develop,
manufacture, register, use, market, import, offer for sale, and sell its HIV
vaccine candidates, including the AIDSVAX
B / E
vaccine.